TRIP12-SLC16A14 Fusion FISH Probe
The TRIP12-SLC16A14 Fusion FISH Probe is used to confirm a fusion of the TRIP12 and SLC16A14 genes. The fusion of the TRIP12 and SLC16A14 genes has been associated with Lung Adenocarcinoma, Kidney Renal Clear Cell Carcinoma, Kidney Renal Clear Cell Carcinoma, and Pheochromocytoma And Paraganglioma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TRIP12-SLC16A14-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TRIP12-SLC16A14-20-AQAQ | 20 (40 μL) | 200 μL |
|
TRIP12 Gene Summary
The protein encoded by this gene is an E3 ubiquitin-protein ligase involved in the degradation of the p19ARF/ARF isoform of CDKN2A, a tumor suppressor. The encoded protein also plays a role in the DNA damage response by regulating the stability of USP7, which regulates tumor suppressor p53. [provided by RefSeq, Jan 2017]
Gene Name: Thyroid Hormone Receptor Interactor 12
Chromosome: CHR2: 230631929 -230786655
Locus: 2q36.3
SLC16A14 Gene Summary
The Solute Carrier Family 16 Member 14 (SLC16A14) gene is located on chr2 :230899689-230933715 at 2q36.3.
Gene Name: Solute Carrier Family 16 Member 14
Chromosome: CHR2: 230899689 -230933715
Locus: 2q36.3
Gene Diseases
The TRIP12 SLC16A14 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
| Kidney Renal Clear Cell Carcinoma |
| Kidney Renal Clear Cell Carcinoma |
| Pheochromocytoma And Paraganglioma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|